Purchase by Todisco Joseph of 5000 shares of CorMedix
| CRMD Stock | USD 11.68 0.52 4.66% |
About 55% of CorMedix's shareholders are presently thinking to get in. The analysis of overall sentiment of trading CorMedix stock suggests that some investors are interested at this time. The current market sentiment, together with CorMedix's historical and current headlines, can help investors time the market. In addition, many technical investors use CorMedix stock news signals to limit their universe of possible portfolio assets.
Filed transaction by Cormedix Inc director. General open market or private purchase of non-derivative or derivative security
Read at macroaxis.com
CorMedix Fundamental Analysis
We analyze CorMedix's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CorMedix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CorMedix based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
CorMedix is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
CorMedix Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with CorMedix stock to make a market-neutral strategy. Peer analysis of CorMedix could also be used in its relative valuation, which is a method of valuing CorMedix by comparing valuation metrics with similar companies.
Peers
CorMedix Related Equities
| LYRA | Lyra Therapeutics | 10.00 | ||||
| SGMO | Sangamo Therapeutics | 6.56 | ||||
| ELDN | Eledon Pharmaceuticals | 4.53 | ||||
| TARS | Tarsus Pharmaceuticals | 1.94 | ||||
| KRON | Kronos Bio | 1.41 | ||||
| TVTX | Travere Therapeutics | 1.40 | ||||
| CNTB | Connect Biopharma | 1.27 | ||||
| GOSS | Gossamer Bio | 0.92 | ||||
| CELC | Celcuity LLC | 0.59 | ||||
| ETON | Eton Pharmaceuticals | 2.00 | ||||
| NVCT | Nuvectis Pharma | 2.23 | ||||
| NUVB | Nuvation Bio | 2.39 | ||||
| PGEN | Precigen | 3.57 | ||||
| ABOS | Acumen Pharmaceuticals | 3.85 | ||||
| ALDX | Aldeyra | 4.29 | ||||
| REPL | Replimune | 4.53 | ||||
| ELVN | Enliven Therapeutics | 7.21 | ||||
| INBX | Inhibrx | 10.77 |
Complementary Tools for CorMedix Stock analysis
When running CorMedix's price analysis, check to measure CorMedix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CorMedix is operating at the current time. Most of CorMedix's value examination focuses on studying past and present price action to predict the probability of CorMedix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CorMedix's price. Additionally, you may evaluate how the addition of CorMedix to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |